Peanuts for Cardiometabolic, Brain, and Intestinal Health (NCT06867198) | Clinical Trial Compass
RecruitingNot Applicable
Peanuts for Cardiometabolic, Brain, and Intestinal Health
United States72 participantsStarted 2025-03-06
Plain-language summary
The overall objective of this 14-month randomized crossover study is to seek evidence demonstrating that daily consumption of peanuts and peanut products improve cardiometabolic, cognitive, and intestinal health in a racially diverse prediabetes population.
Who can participate
Age range20 Years – 59 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* men and women
* 20-59 years of age
* BMI: 24.5 - 35.5 kg/m\^2
* Prediabetes (fasting blood glucose levels 100-125 mg/dL and/or HbA1c between 5.7-6.4%)
* Ability to give consent
Exclusion Criteria:
* Allergies to peanuts and peanut products
* Use of insulin, antidiabetic, antibiotics, and anti-inflammatory drugs
* Active cancer, gastrointestinal, renal, cardiovascular, thyroid, and neurological diseases or severe head injury
* Smoking
* Consumes greater than 2 alcoholic beverages per day
* Consumes antioxidant, probiotic, and prebiotic supplements
* Pregnant or Lactating
* Actively participating in a weight loss program
MRI Exclusion Criteria:
* Certain neurological disorders (e.g., uncontrolled seizure disorders)
* Braces on their teeth, a cardiac pacemaker; hearing aid; other metal in the body or eyes (which may include certain metallic-embedded tattoos), including but not limited to pins, screws, shrapnel, plates, dentures or other metal objects